-
Review
October 2, 2024
- Roles of X-box binding protein 1 in liver pathogenesis
- Jihoon Tak, Yun Seok Kim, Sang Geon Kim
- Clin Mol Hepatol. 2025;31(1):1-31.
Articles in E-pub version are posted online ahead of regular printed publication.
- Reply to Correspondence
- Reply to correspondence on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yoon-su Ha, Won Kim, Seung-Jin Kim
- Received February 4, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0128 [Accepted]
-
View: 62 Download: 1
- Correspondence
- Addressing the Burden of Steatotic Liver Disease: The Role of Transient Elastography: Correspondence to editorial on “Vibration-controlled transient elastography in shaping the epidemiology and management of steatotic liver disease”
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
- Received February 4, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0125 [Accepted]
-
View: 58 Download: 5
- Correspondence to editorial on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
- Soon Kyu Lee, Jong Young Choi
- Received February 3, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0121 [Accepted]
-
View: 50 Download: 1
- GOLM1 and Bile Acid Synthesis: Correspondence to the Editorial “Bridging the Gap: The GOLM1-OPN-ABCG5 Axis in MASH and Gallstone Disease”
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
- Received February 3, 2025 Accepted February 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0120 [Accepted]
-
View: 52 Download: 5
- Editorial
- Is AMA M2 a Useful Serologic Test for Screening High-Risk Patients for PBC?
- Nae-Yun Heo
- Received February 3, 2025 Accepted February 11, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0117 [Accepted]
-
View: 42 Download: 1
- Can SAFE score be utilized as a universal hepatocellular carcinoma prediction score? Editorial on “High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease”
- Michael Kwan-Lung Ko, Loey Lung-Yi Mak
- Received February 3, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0118 [Accepted]
-
View: 84 Download: 10
- Risk stratification for hepatocellular carcinoma in metabolic dysfunction-associated steatotic liver disease
- Ho Soo Chun, Minjong Lee
- Received February 2, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0116 [Accepted]
-
View: 87 Download: 6
- Tetraspan(in)-mediated immune regulation in hepatocellular carcinoma
- Seo Hee Jin, Dong Joo Kim, Jung Weon Lee
- Received January 31, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0109 [Accepted]
-
View: 119 Download: 23
- Screening of patients at high risk of De Novo recurrence in HCC: Editorial on “Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular carcinoma”
- Ping Huang, Shiqiao Luo, Rui Liao
- Received January 30, 2025 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0106 [Accepted]
-
View: 87 Download: 9
- Correspondence
- TIPS insertion and systemic inflammation: Is it ever too late to lower portal pressure?
- Anja Tiede, Benjamin Maasoumy
- Received February 6, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0135 [Accepted]
-
View: 80 Download: 5
- Editorial
- Burden of alcohol use disorder, alcohol-related liver disease, and alcohol-related liver cancer
- Youxin Wang, Noriko Oza, Jazleen Leo, Ashok Choudhury, Daniel Q. Huang
- Received February 5, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0133 [Accepted]
-
View: 210 Download: 14
- TM4SF1 - A new immune target for treatment of hepatocellular carcinoma
- Chen Rui YUAN, Terence Kin Wah LEE
- Received January 29, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0102 [Accepted]
-
View: 106 Download: 10
- Correspondence
- Correspondence to letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
- Soon Kyu Lee, Jong Young Choi
- Received January 28, 2025 Accepted February 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0100 [Accepted]
-
View: 102 Download: 6
- Original Article
- Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
- Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, Shu-Ya Cao, Chen-Yu Jiao, Ming Lu, Biao Zhang, Yue Yang, Qing Xu, Xiao-Feng Wu, Ke Wang, Yong-Xiang Xia, Xiang-Cheng Li, Xue-Hao Wang
- Received October 9, 2024 Accepted February 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0895 [Accepted]
-
View: 1004 Download: 48
- Letter to the Editor
- Letter to the editor on “Bariatric surgery reduces long-term mortality in patients with metabolic dysfunction-associated steatotic liver disease and cirrhosis”
- Chi-Kuei Hsu, Po-Yu Huang, Chih-Cheng Lai
- Received January 19, 2025 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0073 [Accepted]
-
View: 116 Download: 7
- Snapshot
- Interventions Targeting the Gut-Liver Axis: A Potential Treatment Strategy for MASLD
- Pingping Jin, Xinyi Lu, Daozhen Chen, Yu Chen
- Received December 2, 2024 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1090 [Accepted]
-
View: 152 Download: 25
- Original Article
- GULP1 as a Novel Diagnostic and Predictive Biomarker in Hepatocellular Carcinoma
- Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, Moon Gyeong Yoon, Geum Ok Baek, Minji Kang, Se Ha Jang, Won Park, Yunjin Go, Jestlin Tianthing Ng, Suk Woo Nam, Jee-Yeong Jeong, Ji Eun Han, Hyo Jung Cho, Su Bin Lim, Soon Sun Kim, Jae Youn Cheong, Jung Woo Eun
- Received November 19, 2024 Accepted February 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1038 [Accepted]
-
View: 511 Download: 140
- Correspondence
- Correspondence to Editorial on “Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma”
- Weifeng Zeng, Furong Liu, Yachong Liu, Zhanguo Zhang
- Received January 22, 2025 Accepted February 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0085 [Accepted]
-
View: 134 Download: 10
- Review
- Deciphering adenosine signaling in hepatocellular carcinoma: pathways, prognostic models, and therapeutic implications
- Huihai Yang, Martina Mang Leng Lei, Longfei Xie, Yinuo Shou, Terence Kin Wah Lee
- Received November 26, 2024 Accepted February 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1068 [Accepted]
-
View: 354 Download: 43
- Original Article
- Direct-acting antiviral therapy for patients with HCV-related hepatocellular carcinoma: A nationwide cohort study
- Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, Chung-Feng Huang, Chi-Yi Chen, Chao-Hung Hung, Chien-Hung Chen, Chi-Ming Tai, Pin-Nan Cheng, Hsing-Tao Kuo, Kuo-Chih Tseng, Lein-Ray Mo, Ching-Chu Lo, Yi-Hsiang Huang, Han-Chieh Lin, Pei-Lun Lee, Ming-Jong Bair, Te-Sheng Chang, Chun-Yen Lin, Szu-Jen Wang, Tsai-Yuan Hsieh, Tzeng-Hue Yang, Cheng-Yuan Peng, Chi-Chieh Yang, Lee-Won Chong, Chien-Wei Huang, Chih-Wen Lin, Cheng-Hsin Chu, Ming-Chang Tsai, Jia-Horng Kao, Chun-Jen Liu, Wan-Long Chuang, Teng-Yu Lee, Ming- Lung Yu, on behalf of TACR investigators
- Received November 10, 2024 Accepted January 16, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1015 [Accepted]
-
View: 392 Download: 35
- FIB-4plus Score: A novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): An international multicenter study
- Bingtian Dong, Ruiling He, Shenghong Ju, Yuping Chen, Ivica Grgurevic, Jianzhong Ma, Ying Guo, Huizhen Fan, Qiang Yan, Chuan Liu, Huixiong Xu, Anita Madir, Kristian Podrug, Jia Wang, Linxue Qian, Zhengzi Geng, Shanghao Liu, Tao Ren, Guo Zhang, Kun Wang, Meiqin Su, Fei Chen, Sumei Ma, Liting Zhang, Zhaowei Tong, Yonghe Zhou, Xin Li, Fanbin He, Hui Huan, Wenjuan Wang, Yunxiao Liang, Juan Tang, Fang Ai, Tingyu Wang, Liyun Zheng, Zhongwei Zhao, Jiansong Ji, Wei Liu, Jiaojiao Xu, Bo Liu, Xuemei Wang, Yao Zhang, Qiong Yan, Hui Liu, Xiaomei Chen, Shuhua Zhang, Yihua Wang, Yang Liu, Li Yin, Yanni Liu, Yanqing Huang, Li Bian, Ping An, Xin Zhang, Shaoting Zhang, Jinhua Shao, Xiangman Zhang, Wei Rao, Chaoxue Zhang, Dietrich Christoph Frank, Won Kim, Xiaolong Qi
- Received October 10, 2024 Accepted February 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0898 [Accepted]
-
View: 518 Download: 50
- GDH1-dependent α-ketoglutarate promotes HBV transcription by modulating histone methylations on the cccDNA minichromosome
- Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, Xin He, Hui Zhang, Ming Tan, Hai-Bo Yu, Zhen-Zhen Zhang, Ji-Hua Ren, Min-Li Yang, Da-Peng Zhang, Zhi-Hong Li, Juan Chen
- Received August 21, 2024 Accepted January 28, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0694 [Accepted]
-
View: 301 Download: 54
- Baveno VI-SSM stratifies the risk of portal hypertension-related events in patients with HBV-related cirrhosis
- Haiyu Wang, Weihao Liang, Ling Zhou, Jiankang Song, Biao Wen, Qiaoping Wu, Yuanjian Zhang, Xiaofeng Zhang, Haoran Ke, Yujun Tang, Fuyuan Zhou, Youfu Zhu, Weiqun Wen, Zhihua Liu, Yali Ji, Qintao Lai, Qinjun He, Wenfan Luo, Tingting Qi, Miaoxia Liu, Xiaoqin Lan, Yongpeng Chen, Ranran Xi, Junting Wan, Lin Dai, Yuan Li, Jinjun Chen
- Received July 29, 2024 Accepted January 29, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0609 [Accepted]
-
View: 221 Download: 21
- Reply to Correspondence
- Reply to correspondence to editorial on “Bariatric Surgery Reduces Long-Term Mortality in Patients with MASLD and Cirrhosis”
- Jing Zeng, Jian-Gao Fan
- Received January 19, 2025 Accepted January 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0070 [Accepted]
-
View: 156 Download: 9
- Editorial
- Bridging the Gap: The GOLM1-OPN-ABCG5 Axis in MASH and Gallstone Disease: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Nahee Hwang, Sungsoon Fang
- Received January 17, 2025 Accepted January 24, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0066 [Accepted]
-
View: 192 Download: 18
- Correspondence
- Correspondence to editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Jing Lin, Jin-Hong Chen
- Received January 21, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0079 [Accepted]
-
View: 152 Download: 21
- Editorial
- Intrapatient variability of tacrolimus trough level may be not the cause, but an indirect parameter of comorbidities
- Jongman Kim
- Received January 20, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0076 [Accepted]
-
View: 154 Download: 20
- Genetic Insights into Sarcomatoid Hepatocellular Carcinoma: Critical Role of ARID2 in Pathogenesis and Immune Feature
- Naoshi Nishida
- Received January 19, 2025 Accepted January 23, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0071 [Accepted]
-
View: 163 Download: 13
- Review
- Unveiling the Intratumor Microbiome in Liver Cancer: Current Insights and Prospective Applications
- Xindi Ke, Shangze Jiang, Qiaoxin Wei, Minghao Sun, Hang Sun, Mingchang Pang, Mei Liu, Lejia Sun, Huayu Yang, Yilei Mao
- Received November 19, 2024 Accepted January 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1039 [Accepted]
-
View: 388 Download: 46
- Update on the treatment navigation for functional cure of chronic hepatitis B: expert consensus 2.0
- Di Wu, Jia-Horng Kao, Teerha Piratvisuth, Xiaojing Wang, Patrick T.F. Kennedy, Motoyuki Otsuka, Sang Hoon Ahn, Yasuhito Tanaka, Guiqiang Wang, Zhenghong Yuan, Wenhui Li, Young-Suk Lim, Junqi Niu, Fengmin Lu, Wenhong Zhang, Zhiliang Gao, Apichat Kaewdech, Meifang Han, Weiming Yan, Hong Ren, Peng Hu, Sainan Shu, Paul Yien Kwo, Fu-sheng Wang, Man-Fung Yuen, Qin Ning
- Received September 9, 2024 Accepted January 21, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0780 [Accepted]
-
View: 762 Download: 154
- Original Article
- Modulation of PRL-1 within placental MSCs instigates the transition between EMT and MET subsequent to hepatic fibrosis
- Jae Yeon Kim, Hyeri Park, Soo Young Park, Se Ho Kim, Ja Yun Lim, Ki Seog Lee, Si Hyun Bae, Gi Jin Kim
- Received September 12, 2024 Accepted January 20, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0741 [Accepted]
-
View: 3595 Download: 673
- Letter to the Editor
- What is new in the 2024 Chinese guidelines for fatty liver disease?
- Rui-Xu Yang, Vincent Wai-Sun Wong, Jian-Gao Fan
- Received December 27, 2024 Accepted January 18, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1165 [Accepted]
-
View: 201 Download: 21
- Original Article
- Switching to Besifovir in Patients with Chronic Hepatitis B Receiving Tenofovir Disoproxil Fumarate: A Randomized Trial
- Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, Won Kim, Young Kul Jung, Jae Young Jang, Sae Hwan Lee, Yun Soo Kim, Chang Wook Kim, Hyoung Su Kim, Jae-Jun Shim, Eun-Young Cho, In Hee Kim, Byung Seok Lee, Jeong-Hoon Lee, Byung Seok Kim, Jeong Won Jang, Hyun Woong Lee, Jung Hyun Kwon, Moon Young Kim, Do Seon Song, Jung Gil Park, Yoon Seok Lee, Eileen L. Yoon, Han Ah Lee, Seong Hee Kang, Jin Mo Yang
- Received September 19, 2024 Accepted January 16, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0819 [Accepted]
-
View: 483 Download: 37
- Editorial
- Unraveling the role of GOLM1-OPN-ABCG5 axis in MASH: Editorial on “GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers”
- Yoon-su Ha, Won Kim, Seung-Jin Kim
- Received January 10, 2025 Accepted January 13, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0036 [Accepted]
-
View: 336 Download: 25
- Reply to Correspondence
- Reply to correspondence on “Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis”
- Hyuk Soo Eun
- Received January 10, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0035 [Accepted]
-
View: 258 Download: 10
- Editorial
- Targeting TM4SF1 to overcome immunotherapy resistance in hepatocellular carcinoma
- Valerie Chew
- Received January 9, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0031 [Accepted]
-
View: 250 Download: 25
- Revealing the Importance of a Multidisciplinary Approach to Reducing the Global Burden of SLD Through the COVID-19 Pandemic: Editorial on “Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023”
- Jeayeon Park, Su Jong Yu
- Received January 6, 2025 Accepted January 12, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0019 [Accepted]
-
View: 224 Download: 5
- Original Article
- Exploring Methylation Signatures for High De Novo Recurrence Risk in Hepatocellular carcinoma
- Da-Won Kim, Jin Hyun Park, Suk Kyun Hong, Min-Hyeok Jung, Ji-One Pyeon, Jin-Young Lee, Kyung-Suk Suh, Nam-Joon Yi, YoungRok Choi, Kwang-Woong Lee, Young-Joon Kim
- Received October 11, 2024 Accepted January 7, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0899 [Accepted]
-
View: 254 Download: 26
- Correspondence
- Correspondence to Editorial on “Bariatric Surgery Reduces Long-Term Mortality in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Cirrhosis”
- Nicholas A. Rouillard, Linda Henry, Mindie H. Nguyen
- Received January 1, 2025 Accepted January 4, 2025
-
DOI: https://doi.org/10.3350/cmh.2025.0001 [Accepted]
-
View: 256 Download: 13
- Letter to the Editor
- Tacrolimus Levels and Variability in CKD and ESRD Risk Post-Liver Transplant
- Rui Shi, Minghua Wang
- Received December 21, 2024 Accepted January 6, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1159 [Accepted]
-
View: 251 Download: 16
- Original Article
- Adverse impact of metabolic dysfunction on fibrosis regression following direct-acting antiviral therapy: A multicenter study for chronic hepatitis C
- Tom Ryu, Young Chang, Soung Won Jeong, Jeong-Ju Yoo, Sae Hwan Lee, Sang Gyune Kim, Young Seok Kim, Hong Soo Kim, Seung Up Kim, Jae Young Jang
- Received October 12, 2024 Accepted January 5, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0904 [Accepted]
-
View: 354 Download: 40
- Global Epidemiology of Alcohol-Related Liver Disease, Liver Cancer, and Alcohol Use Disorder, 2000–2021
- Pojsakorn Danpanichkul, Luis Antonio Díaz, Kanokphong Suparan, Primrose Tothanarungroj, Supapitch Sirimangklanurak, Thanida Auttapracha, Hanna L. Blaney, Banthoon Sukphutanan, Yanfang Pang, Siwanart Kongarin, Francisco Idalsoaga, Eduardo Fuentes-López, Lorenzo Leggio, Mazen Noureddin, Trenton M. White, Alexandre Louvet, Philippe Mathurin, Rohit Loomba, Patrick S. Kamath, Jürgen Rehm, Jeffrey V. Lazarus, Karn Wijarnpreecha, Juan Pablo Arab
- Received September 26, 2024 Accepted January 3, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0835 [Accepted]
-
View: 1135 Download: 124 Crossref: 1
- Correspondence
- Correspondence on Editorial regarding “Usefulness of circulating cell-free mitochondrial DNA on hepatocellular carcinoma diagnosis and prognosis assessment”
- Yang Liu, Fan Peng, Siyuan Wang, Jinliang Xing
- Received December 30, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1185 [Accepted]
-
View: 213 Download: 19
- Editorial
- Treating systemic inflammation by transjugular intrahepatic portosystemic shunt
- Georg Semmler, Lorenz Balcar, Mattias Mandorfer
- Received January 29, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1180 [Accepted]
-
View: 251 Download: 27
- Correspondence
- Reply to “MAFLD or MASLD: Which Better Represents the Prognosis of the Steatotic Liver Population”
- Seogsong Jeong, Won Kim, Sang Min Park
- Received December 26, 2024 Accepted January 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1175 [Accepted]
-
View: 368 Download: 15
- Reply to “Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma”
- Seogsong Jeong, Won Kim, Sang Min Park
- Received December 23, 2024 Accepted January 2, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.1171 [Accepted]
-
View: 332 Download: 13
- Original Article
- High SAFE scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction associated steatotic liver disease
- Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, Wei-Yu Kao, Shang-Chin Huang, Fen-Fang Chen, Francis SK Poon, Lung-Wen Tsai, Yi-Ting Chen, Che Lin, Weichung Wang, W Ray Kim, Jia-Horng Kao
- Received September 21, 2024 Accepted January 1, 2025
-
DOI: https://doi.org/10.3350/cmh.2024.0822 [Accepted]
-
View: 716 Download: 62
- Male preference for TERT alterations and HBV integration in young-age HBV-related HCC: implications for sex disparity
- Jin Seoub Kim, Hye Seon Kim, Kwon Yong Tak, Ji Won Han, Heechul Nam, Pil Soo Sung, Sung Won Lee, Jung Hyun Kwon, Si Hyun Bae, Jong Young Choi, Seung Kew Yoon, Jeong Won Jang
- Received July 10, 2024 Accepted December 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0545 [Accepted]
-
View: 503 Download: 44
- Correspondence
- Age serves as the silent architect of FIB-4's precision in unveiling advanced hepatic fibrosis in MASLD with T2DM
- Ji Won Han, Dae Won Jun
- Received December 22, 2024 Accepted December 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1160 [Accepted]
-
View: 241 Download: 19
- Letter to the Editor
- Current Burden of MASLD, MetALD, and Hepatic Fibrosis among US Adults with Prediabetes and Diabetes, 2017-2023
- Donghee Kim, Rohit Loomba, Aijaz Ahmed
- Received December 20, 2024 Accepted December 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1150 [Accepted]
-
View: 685 Download: 90
- Original Article
- Targeting TM4SF1 promotes tumor senescence enhancing CD8+ T cell cytotoxic function in hepatocellular carcinoma
- Weifeng Zeng, Furong Liu, Yachong Liu, Ze Zhang, Haofan Hu, Shangwu Ning, Hongwei Zhang, Xiaoping Chen, Zhibin Liao, Zhanguo Zhang
- Received October 28, 2024 Accepted December 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0934 [Accepted]
-
View: 886 Download: 141
- Prediction of primary biliary cholangitis among health check-up population with anti-mitochondrial M2 antibody positive
- Haolong Li, Song Liu, Xu Wang, Xinxin Feng, Siyu Wang, Yanli Zhang, Fengchun Zhang, Li Wang, Tengda Xu, Yongzhe Li
- Received June 3, 2024 Accepted December 25, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0416 [Accepted]
-
View: 428 Download: 53
- Editorial
- Circulating cell-free mitochondrial DNA for diagnosing hepatocellular carcinoma and assessing prognosis
- Hyuk soo Eun
- Received December 15, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1133 [Accepted]
-
View: 307 Download: 26
- Vibration-Controlled Transient Elastography in Shaping the Epidemiology and Management of Steatotic Liver Disease
- Xiao-Dong Zhou, Terry Cheuk-Fung Yip, Daniel Q Huang, Mark Dhinesh Muthiah, Mazen Noureddin, Ming-Hua Zheng
- Received December 14, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1131 [Accepted]
-
View: 608 Download: 35
- Review
- Liver organoids: Current advances and future applications for hepatology
- Yohan Kim, Minseok Kang, Michael Girma Mamo, Michael Adisasmita, Meritxell Huch, Dongho Choi
- Received November 19, 2024 Accepted December 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1040 [Accepted]
-
View: 906 Download: 156
- Letter to the Editor
- MAFLD or MASLD: Which Better Represents the Prognosis of the Steatotic Liver Population
- Ying Wang, Shengfeng Wang, Xiude Fan, Jiajun Zhao, Yongfeng Song
- Received November 8, 2024 Accepted December 24, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1008 [Accepted]
-
View: 548 Download: 53 Crossref: 1
- Review
- Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
- Soo Young Hwang, Pojsakorn Danpanichkul, Vatche Agopian, Neil Mehta, Neehar D. Parikh, Ghassan K. Abou-Alfa, Amit G. Singal, Ju Dong Yang
- Received September 22, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0824 [Accepted]
-
View: 2078 Download: 423 Crossref: 1
- Original Article
- Longitudinal profile of plasma pregenomic RNA in patients with chronic hepatitis B infection on long-term nucleoside analogues and its interaction with clinical parameters
- Lung-Yi Mak, Mark Anderson, Michael Stec, Matthew Shing-Hin Chung, Danny Ka-Ho Wong, Rex Wan-Hin Hui, Wai-Kay Seto, Gavin Cloherty, Man-Fung Yuen
- Received August 27, 2024 Accepted December 21, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0724 [Accepted]
-
View: 508 Download: 49
- Correspondence
- Expanding Treatment Eligibility for Chronic Hepatitis B: Balancing Benefits, Limitations, and Healthcare Access
- Yao-Chun Hsu, Chi-Yi Chen, Jaw-Town Lin
- Received December 16, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1138 [Accepted]
-
View: 265 Download: 12
- Original Article
- MARC1 downregulation reduces hepatocyte lipid content by increasing beta-oxidation
- Ester Ciociola, Tanmoy Dutta, Kavitha Sasidharan, Lohitesh Kovooru, Francesca R. Noto, Grazia Pennisi, Salvatore Petta, Angela Mirarchi, Samantha Maurotti, Bernardette Scopacasa, Luca Tirinato, Patrizio Candeloro, Marcus Henricsson, Daniel Lindén, Oveis Jamialahmadi, Arturo Pujia, Rosellina M. Mancina, Stefano Romeo
- Received August 13, 2024 Accepted December 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0642 [Accepted]
-
View: 1010 Download: 187
- Editorial
- A leap in the dark: Bariatric surgery for treatment of metabolic dysfunction-associated steatotic liver disease related cirrhosis
- Jing Zeng, Jian-Gao Fan
- Received December 5, 2024 Accepted December 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1099 [Accepted]
-
View: 386 Download: 28
- Letter to the Editor
- Comment on: Evolutionary changes in metabolic dysfunction-associated steatotic liver disease and risk of hepatocellular carcinoma
- Hai Xu, Yong Zhou, Huikun Wu
- Received December 2, 2024 Accepted December 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1087 [Accepted]
-
View: 403 Download: 12
- Global Inequality in the Burden of Hepatitis B From 1990 to 2021: Findings From the Global Burden of Disease Study 2021
- Chunlong Liu, Jiangtao Yu
- Received December 1, 2024 Accepted December 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1085 [Accepted]
-
View: 472 Download: 64
- Original Article
- Plasma lipidomics and fungal peptide-based community analysis identifies distinct signatures of early mortality in acute liver failure
- Neha Sharma, Sushmita Pandey, Gaurav Tripathi, Manisha Yadav, Nupur Sharma, Babu Mathew, Abhishak Gupta, Vasundhra Bindal, Sadam H. Bhat, Yash magar, Rimsha Saif, Sanju Yadav, Amritpal Kaur, Rakhi Maiwall, Shvetank Sharma, Shiv Kumar Sarin, Jaswinder Singh Maras
- Received July 12, 2024 Accepted December 10, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0554 [Accepted]
-
View: 710 Download: 71
- Review Article
- Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
- Chenyang Li, Chujun Cai, Chendong Wang, Xiaoping Chen, Bixiang Zhang, Zhao Huang
- Received September 30, 2024 Accepted December 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0857 [Accepted]
-
View: 833 Download: 112
- Prediction and Management of Small-for-Size Syndrome in Living Donor Liver Transplantation
- Jia-hao Law, Alfred Wei-Chieh Kow
- Received October 3, 2024 Accepted December 9, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0870 [Accepted]
-
View: 407 Download: 49
- Original Article
- Integrated Molecular Characterization of Sarcomatoid Hepatocellular Carcinoma
- Rong-Qi Sun, Yu-Hang Ye, Ye Xu, Bo Wang, Si-Yuan Pan, Ning Li, Long Chen, Jing-Yue Pan, Zhi-Qiang Hu, Jia Fan, Zheng-Jun Zhou, Jian Zhou, Cheng-Li Song, Shao-Lai Zhou
- Received August 21, 2024 Accepted December 6, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0686 [Accepted]
-
View: 794 Download: 86
- GOLM1 promotes cholesterol gallstone formation via ABCG5-mediated cholesterol efflux in MASH livers
- Yi-Tong Li, Wei-Qing Shao, Zhen-Mei Chen, Xiao-Chen Ma, Chen-He Yi, Bao-Rui Tao, Bo Zhang, Yue Ma, Guo Zhang, Rui Zhang, Yan Geng, Jing Lin, Jin-Hong Chen
- Received August 12, 2024 Accepted December 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0657 [Accepted]
-
View: 927 Download: 159 Crossref: 1
- Editorial
- Reconsidering Treatment Indications for Chronic Hepatitis B: Insights from the TORCH-B Roll-Over Study
- Chih-Wen Wang, Ming-Lung Yu
- Received November 28, 2024 Accepted November 30, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1078 [Accepted]
-
View: 342 Download: 12
- Letter to the Editor
- Treatment response to nucleos(t)ide analogs in chronic hepatitis B with mildly elevated alanine aminotransferase
- Jian Wang, Fei Cao, Chuanwu Zhu, Chao Wu, Rui Huang
- Received October 29, 2024 Accepted November 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0960 [Accepted]
-
View: 324 Download: 16
- Original Article
- Cost-effectiveness and return on investment of hepatitis C virus elimination in China: A modelling study
- Meiyu Wu, Jing Ma, Xuehong Wang, Sini Li, Chongqing Tan, Ouyang Xie, Andong Li, Aaron G Lim, Xiaomin Wan
- Received August 13, 2024 Accepted December 2, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0664 [Accepted]
-
View: 697 Download: 104
- Correspondence
- HCV Self-Testing: Bridging Screening Gaps and Ensuring Cost-Effectiveness for Both High-Risk and Universal Populations
- Gyeongseon Shin, Beom Kyung Kim, SeungJin Bae, Hankil Lee, Sang Hoon Ahn
- Received November 23, 2024 Accepted November 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.1057 [Accepted]
-
View: 306 Download: 19
- Original Article
- Current Burden of Steatotic Liver Disease and Fibrosis among Adults in the United States, 2017-2023
- Donghee Kim, Pojsakorn Danpanichkul, Karn Wijarnpreecha, George Cholankeril, Rohit Loomba, Aijaz Ahmed
- Received November 3, 2024 Accepted November 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0987 [Accepted]
-
View: 1617 Download: 295 Crossref: 3
- Review
- Microbiome-Centered Therapies for the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Huma Saeed, Luis Antonio Díaz, Antonio Gil-Gómez, Jeremy Burton, Jasmohan Bajaj, Manuel Romero-Gomez, Marco Arrese, Juan Pablo Arab, Mohammad Qasim Khan
- Received September 13, 2024 Accepted November 20, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0811 [Accepted]
-
View: 2496 Download: 226 Crossref: 1
- Liquid Biopsy in Hepatocellular Carcinoma: Challenges, Advances, and Clinical Implications
- Jaeho Park, Yi-Te Lee, Vatche G. Agopian, Jessica S Liu, Ekaterina K. Koltsova, Sungyong You, Yazhen Zhu, Hsian-Rong Tseng, Ju Dong Yang
- Received July 10, 2024 Accepted November 25, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0541 [Accepted]
-
View: 941 Download: 119
- Review Article
- Mechanisms of HCC and cirrhosis development in concurrent steatotic liver disease and chronic hepatitis B
- Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
- Received September 25, 2024 Accepted November 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0837 [Accepted]
-
View: 885 Download: 94
- Review
- Prospect of emerging treatments for HBV functional cure
- Rex Wan-Hin Hui, Lung-Yi Mak, James Fung, Wai-Kay Seto, Man-Fung Yuen
- Received September 29, 2024 Accepted November 14, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0855 [Accepted]
-
View: 1201 Download: 243 Crossref: 1
- Editorial
- Universal self-testing as a cost-effective weapon to eliminate hepatitis C virus in the Republic of Korea
- Eun Sun Jang
- Received November 5, 2024 Accepted November 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0992 [Accepted]
-
View: 337 Download: 8
- Correspondence
- Correspondence to editorials on “Safety and efficacy of HK-660S in patients with primary sclerosing cholangitis: A randomized double-blind phase 2a trial”
- Woo Hyun Paik, Do Hyun Park
- Received November 4, 2024 Accepted November 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0989 [Accepted]
-
View: 318 Download: 18
- Review
- Hepatitis E as a trigger for Acute-on-Chronic Liver Failure
- Maria Buti, Juan Carlos Ruiz-Cobo, Rafael Esteban, Mar Riveiro-Barciela
- Received September 5, 2024 Accepted November 7, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0758 [Accepted]
-
View: 852 Download: 91
- Stem cell exosomes: new hope and future potential for relieving liver fibrosis
- Lihua Li, Yongjie Liu, Kunpeng Wang, Jinggang Mo, Zhiyong Weng, Hao Jiang, Chong Jin
- Received September 29, 2024 Accepted November 5, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0854 [Accepted]
-
View: 1364 Download: 204
- Editorial
- Stabilizing Hepatic Fatty Acid Oxidation: USP29 Secures Acyl-CoA Synthesis through ACSL5
- Myeung Gi Choi, Na Young Lee, Ja Hyun Koo
- Received October 31, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0971 [Accepted]
-
View: 460 Download: 40
- A novel clinical trial for primary sclerosing cholangitis from Asia: all regional endeavors should improve global management of PSC
- Atsumasa Komori
- Received October 25, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0945 [Accepted]
-
View: 369 Download: 26
- Correspondence
- Correspondence on Letter Regarding “Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults”
- Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
- Received October 25, 2024 Accepted November 1, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0944 [Accepted]
-
View: 392 Download: 9
- Editorial
- Challenges and Innovations in PSC Clinical Trials: Evaluating HK-660S and the Path Forward
- Nilanga Nishad
- Received October 24, 2024 Accepted October 31, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0942 [Accepted]
-
View: 308 Download: 21
- Review
- ALCOHOL-ASSOCIATED LIVER DISEASE: NATURAL HISTORY, MANAGEMENT AND NOVEL TARGETED THERAPIES
- Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós, Ana Clemente-Sánchez, Hugo Hugo López-Pelayo, Ramón Bataller
- Received August 24, 2024 Accepted October 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0709 [Accepted]
-
View: 1148 Download: 177 Crossref: 2
- Editorial
- Momentum Towards Simplifying and Expanding Treatment for Chronic Hepatitis B: The Body of Evidence Continues to Grow
- Robert J. Wong
- Received October 22, 2024 Accepted October 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0929 [Accepted]
-
View: 287 Download: 14
- Letter to the Editor
- Prevalence of steatotic liver disease and associated fibrosis in the general population: an epidemiological survey
- Lin Guan, Xinhe Zhang, Shanghao Liu, Xiaolong Qi, Yiling Li
- Received October 17, 2024 Accepted October 28, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0921 [Accepted]
-
View: 515 Download: 46
- Snapshot
- MODULATION OF LYMPHATIC VESSELS IN MANAGEMENT OF LIVER DISEASE AND COMPLICATIONS
- Aarti Sharma, Pinky Juneja, Shiv K Sarin, Savneet Kaur
- Received September 12, 2024 Accepted October 16, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0793 [Accepted]
-
View: 414 Download: 42
- Correspondence
- Reply to: “From invasive to intuitive: the emerging role of non-invasive models in hepatic decompensation”
- Chuan Liu, Ling Yang, Hong You, Gao-Jun Teng, Xiaolong Qi
- Received August 27, 2024 Accepted August 29, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0723 [Accepted]
-
View: 530 Download: 27
- Editorial
- From Invasive to Intuitive: The Emerging Role of Non-Invasive Models in Hepatic Decompensation
- Akhil Deshmukh, Rakhi Maiwall
- Received August 13, 2024 Accepted August 13, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0661 [Accepted]
-
View: 386 Download: 18
- Review Article
- Epidemiology of Metabolic Dysfunction-Associated Steatotic Liver Disease
- Zobair M. Younossi, Markos Kalligeros, Linda Henry
- Received June 6, 2024 Accepted August 15, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0431 [Accepted]
-
View: 5505 Download: 1,274 Crossref: 18
- Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
- Meng Sha, Jun Wang, Jie Cao, Zhi-Hui Zou, Xiao-ye Qu, Zhi-feng Xi, Chuan Shen, Ying Tong, Jian-jun Zhang, Seogsong Jeong, Qiang Xia
- Received April 30, 2024 Accepted August 12, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0323 [Accepted]
-
View: 1086 Download: 137 Crossref: 1
- Review
- Precision medicine and nucleotide-based therapeutics to treat MASH
- Andrea Caddeo, Stefano Romeo
- Received June 8, 2024 Accepted August 4, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0438 [Accepted]
-
View: 1947 Download: 346 Crossref: 3
- Role of noninvasive tests in the prognostication of metabolic dysfunction-associated steatotic liver disease
- Yue Wang, Sherlot Juan Song, Yichong Jiang, Jimmy Che-To Lai, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
- Received April 10, 2024 Accepted June 26, 2024
-
DOI: https://doi.org/10.3350/cmh.2024.0246 [Epub ahead of print]
-
View: 4786 Download: 164 Crossref: 1
